YU11991A -
RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE
- Google Patents
RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag.filedCriticalImmuno Ag.
Priority to YU11991ApriorityCriticalpatent/YU11991A/en
Publication of YU11991ApublicationCriticalpatent/YU11991A/en
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
REKOMBINANTNO PROIZVEDENI KRVNI FAKTOR IN POSTOPEK ZA EKSPRESIJO TEH KRVNIH FAKTORJEV KOT TUDI REKOMBINANTI VIRUSA VAKCINIJE, KI JIH UPORABLJAMO V TEM POSTOPKU, opisani so rekombinantno proizvedeni krvni faktorji kot tudi postopek za njihovo pripravo, pri čemer imajo ti krvni faktorji razmerje med biološko aktivno obliko in antigensko obliko najmanj 50%, prednostno v območju 60 do 90%. Opisani so tudi rekombinantni virusi vakcinije, ki jih uporabljamo v gornjem postopku. Postopek v skladu z izumom zagotavlja izboljšan sistem ekspresije z visoko postranslacijsko sposobnostjo pod pogoji stabilne ekspresije.RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINATION VIRUS VIRCOMINANTS USED IN THIS PROCEDURE form at least 50%, preferably in the range of 60 to 90%. The recombinant vaccine viruses used in the above procedure are also described. The process according to the invention provides an improved expression system with high post-translational capacity under stable expression conditions.
YU11991A1991-01-241991-01-24
RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE
YU11991A
(en)
THYMIDINE KINASE DELETION MUTANTS OF BOVINE HERPESVIRUS-1, VACCINES AGAINST BOVINE RHINOTRACHEITIS CONTAINING THEM, AND METHODS FOR THEIR MANUFACTURE AND USE.
USE OF QUINOLYL AND ISOQUINOLYLOXAZOLE-2-ONES IN THE MANUFACTURE OF A MEDICATION FOR PREVENTING THE TRANSPORTABILITY OF GLYCOPROTEIN ENVELOPED VIRUSES.